Is telemedicine beneficial for all healthcare conditions, or could this be a good time for pharma to revisit the patient journey and address any gaps?
![](https://static.wixstatic.com/media/04ef19_2f8163987ee348d9a12961458d8a52dc~mv2.jpg/v1/fill/w_147,h_98,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/04ef19_2f8163987ee348d9a12961458d8a52dc~mv2.jpg)
Is telemedicine beneficial for all healthcare conditions, or could this be a good time for pharma to revisit the patient journey and address any gaps?